Anatomy of an American football game: Player-to-player contact before, during and after an NFL game in context of the 2020 COVID-19 pandemic.

COVID-19 Infectious disease NFL SARS-CoV2 contact tracing transmission wearable technology

Journal

The Physician and sportsmedicine
ISSN: 2326-3660
Titre abrégé: Phys Sportsmed
Pays: England
ID NLM: 0427461

Informations de publication

Date de publication:
06 2023
Historique:
medline: 25 5 2023
pubmed: 19 1 2022
entrez: 18 1 2022
Statut: ppublish

Résumé

To quantify levels of potential exposure to SARS-CoV-2 surrounding a typical professional American football game, with a focus on interactions on-field between teammates and opposing players before, during, and immediately after competition. We examined across-Club consecutive interactions ≥2 minutes within 6 feet [1.8 meters] between athletes on opposing Clubs for all 2020 NFL regular season games (n = 256). Cumulative interaction was measured for a representative subset (n = 119; 46%) of games. Wearable proximity tracking devices (Kinexon) were used to measure distance and duration of interactions; these data were combined with game schedule and Club rosters for analyses. Frequency and per-game mean, median, interquartile range for consecutive interactions ≥2/≥5 minutes and cumulative interactions ≥5/≥15 were described overall and stratified by pre-game, in-game, and post-game. Of the 1964 distinct player-to-opponent contacts ≥2 minutes in NFL regular season games, the majority (n = 1,699; 87%) were fewer than 5 minutes in consecutive length. Among the mean 7.7 distinct contacts ≥2 minutes with opponents each game (median = 4; IQR = 2, 8), very few were ≥5 consecutive minutes at any point (mean = 1.0; median = 0; IQR = 0, 0). Most (n = 849; 43.2%) distinct contacts were pre-game, 546 (27.8%) were during competition, and 569 (29%) were post-game. In games where cumulative interactions were analyzed, there was an average of 17.1 player/opponent interactions with cumulative exposure ≥5 minutes (median = 12; IQR = 4, 30), almost all of which occurred during competition. There is limited and short contact between and among competing players in professional American football. In the setting of infectious disease such as the COVID-19 pandemic, a robust prevention program integrating masking, distancing, hygiene, and ventilation when off-field can be created to minimize on- and off-field exposures, which effectively reduces transmission risk in outdoors and/or well-ventilated stadium settings.

Identifiants

pubmed: 35040386
doi: 10.1080/00913847.2022.2028536
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

234-239

Auteurs

Christina D Mack (CD)

IQVIA Real-World Solutions, Research Triangle Park, North Carolina, USA.

Erin B Wasserman (EB)

IQVIA Real-World Solutions, Research Triangle Park, North Carolina, USA.

Deverick J Anderson (DJ)

Department of Medicine, Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, North Carolina, USA.

Gabriel Farkas (G)

IQVIA Real-World Solutions, Research Triangle Park, North Carolina, USA.

Molly Delaney (M)

Player Health and Safety Department, National Football League, New York, NY, USA.

Daniel Eichner (D)

Sports Medicine Research and Testing Laboratory, Salt Lake City, UT, USA.

Kyle Johnston (K)

Athletic Training, Miami Dolphins, Miami, FL, USA.

Madeline K Lassiter (MK)

IQVIA Real-World Solutions, Research Triangle Park, North Carolina, USA.

Emily Myers (E)

Player Health and Safety Department, National Football League, New York, NY, USA.

Thom Mayer (T)

National Football League Players Association, Washington, DC, USA.

Gary Solomon (G)

Player Health and Safety Department, National Football League, New York, NY, USA.

Allen Sills (A)

Player Health and Safety Department, National Football League, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH